Quest Diagnostics raised its 2026 revenue and EPS guidance after reporting strong Q1 results driven by organic growth, collaborations, and digital innovations. Despite this, Hedgeye shifted its rating ...
Highlights include 99.9% accurate monkeypox AI, multi-camera zebrafish assays, and infection-proof titanium implants, showcasing tech-driven leaps in biomedicine and diagnostics SLAS Technology ...
Citi Research analysts weighed in on the performance of North America life science tools & diagnostics companies in the second quarter of 2025, saying that volatility continued across the sector, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results